Capricor Therapeutics, Inc. (CAPR) SEC Filings — 2024

Filings

• Capricor Therapeutics Q3 2024 Financial Update — 10-Q · Nov 14, 2024
• Capricor Therapeutics Files 8-K on Financials — 8-K · Nov 13, 2024
• Capricor Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 12, 2024
• Capricor Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Capricor Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 24, 2024
• Capricor Therapeutics Files 8-K: Material Agreement — 8-K · Oct 17, 2024
• Capricor Therapeutics Closes $100M Public Offering — 8-K · Oct 16, 2024
• Capricor Therapeutics Completes Enrollment in Phase 3 DMD Trial — 8-K · Oct 9, 2024
• Capricor Sells Ex-US CAP-1002 Rights to Sarepta for $100M — 8-K · Sep 24, 2024
• Capricor Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Sep 24, 2024
• Capricor Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 17, 2024
• Capricor Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Aug 23, 2024
• Capricor Therapeutics Q2 2024 Financial Update — 10-Q · Aug 8, 2024
• Capricor Therapeutics Files 8-K on Financials — 8-K · Aug 7, 2024
• Capricor Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · May 15, 2024
• Capricor Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
• Capricor Therapeutics Files 8-K on Financials — 8-K · May 13, 2024
• Capricor Therapeutics Enters Acquisition Term Sheet — 8-K · Apr 29, 2024
• Capricor Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 1, 2024
• Capricor Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 11, 2024
• Capricor Therapeutics Files 8-K on Financial Condition — 8-K · Feb 29, 2024
• Highbridge Capital Discloses New Passive Stake in Capricor Therapeutics — SC 13G · Feb 7, 2024
• Capricor Therapeutics Relocates HQ to San Diego — 8-K · Jan 11, 2024